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ABSTRACT
The field of extracellular vesicles (EVs) is an exponentially growing segment of biomedical
sciences. However, the problems of normalisation and quantification of EV samples have not
been completely solved. Currently, EV samples are standardised on the basis of their protein
content sometimes combined with determination of the particle number. However, even this
combined approach may result in inaccuracy and overestimation of the EV concentration. Lipid
bilayers are indispensable components of EVs. Therefore, a lipid-based quantification, in combi-
nation with the determination of particle count and/or protein content, appears to be
a straightforward and logical approach for the EV field. In this study, we set the goal to improve
the previously reported sulfo-phospho-vanillin (SPV) lipid assay. We introduced an aqueous phase
liposome standard (DOPC) to replace the purified lipid standards in organic solvents (used
commonly in previous studies). Furthermore, we optimised the concentration of the vanillin
reagent in the assay. We found that elimination of organic solvents from the reaction mixture
could abolish the background colour that interfered with the assay. Comparison of the optimised
assay with a commercial lipid kit (based on the original SPV lipid assay) showed an increase of
sensitivity by approximately one order of magnitude. Thus, here we report a quick, reliable and
sensitive test that may fill an existing gap in EV standardisation. When using the optimised lipid
assay reported here, EV lipid measurements can be more reliable than protein-based measure-
ments. Furthermore, this novel assay is almost as sensitive and as easy as measuring proteins with
a simple BCA test.
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Introduction
The field of extracellular vesicles (EVs) attracts sub-
stantial attention in biomedicine due to the proposed
role of EVs in various biological processes and their
potential to serve as biomarkers for diseases [1–3].
However, the availability of approaches for standar-
dised quantification of EVs is limited [4–6]. Current
interest in EV research urges reliable tools of standar-
disation and accurate enumeration of EVs.
One of the main problems is that contaminants of
EV-enriched samples (such as protein aggregates and
lipoproteins) may share biophysical parameters with
EVs [7–9]. Particle enumeration methods (including
nanoparticle tracking analysis and tuneable resistive
pulse sensing) are error-prone because they cannot
distinguish vesicular and non-vesicular structures.
Methods used commonly for standardisation of EVs
rely on the measurement of total proteins with colori-
metric reactions (e.g. Micro BCA). Importantly, by
definition, EVs are surrounded by phospholipid
bilayers [5,10]; therefore, lipids (such as phospholipids
and cholesterol) are essential components of all EVs.
Ideally, lipid detection would help to distinguish pro-
tein aggregates from EVs. However, differentiation
between EVs and lipoproteins still remains challenging.
Quantification and standardisation of EV samples
based on lipid content, and estimation of EV purity
based on protein to lipid ratio, have been prevented
until recently by the lack of suitable methods. In
2015, our group has published that a simple bench-
top colorimetric lipid assay (the sulfo-phospho-
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vanillin [SPV]) was suitable to determine the lipid
content of EVs and to determine the protein/lipid
(P/L) ratio of EV preparations [11]. However, the
broad use of this assay was prevented by its rela-
tively low sensitivity which implies that a significant
proportion of an EV preparation was required for
the lipid test [6]. Infrared (IR) spectroscopy was
also used to determine the same P/L ratio of EV
samples as determined by the SPV assay [12], but it
requires equipment usually not available in biome-
dical laboratories. An alternative approach is mass
spectroscopy (MS)-based lipid quantification; how-
ever, it still has strong dependence on equipment,
requires higher sample amounts, has long proces-
sing time and the technique may not be readily
available to all laboratories [2].
As pointed out by a recent review, lipid quantifica-
tion focuses on the defining component of EVs: the
lipid bilayer [6]. As highlighted in the above article,
until now there has been an important and urgent need
for a more sensitive benchtop lipid quantification
assay. Here, we report that we developed an improved
version of our previous vanillin-based lipid assay
detecting unsaturated lipid components of biological
membranes. We have substantially increased the sensi-
tivity of the lipid test compared to the previous assay
making it suitable for routine quantification of most
EV samples. This assay provides a more reliable
method to measure EVs than protein-based measure-
ment. It measures lipids even from a limited amount of
samples with a sensitivity close to that of the Micro
BCA assay.
Material and methods
Cell lines
AC16 human cardiomyocyte cell line (SCC109) was
purchased from Merck and was cultured according to
the instructions of the manufacturer. Before EV isola-
tion, AC16 cells were differentiated according to the
work of Davidson [13]. Cells were cultured in tissue
culture flasks coated with 0.02% gelatine (EMD
Millipore) and 5 µg/mL fibronectin (Gibco) up to con-
fluence. Once the cells reached confluence, they were
cultured for an additional week in DMEM/F12 med-
ium supplemented with 2% horse serum and 1x
Insulin-Transferrin-Selenium (all from Gibco). EVs
were isolated from serum-free conditioned medium.
H9c2 (2-1) BDIX rat heart myoblast cell line was
purchased from ECACC through Sigma-Merck. Cells
were cultured in DMEMmedium (Sigma) supplemented
with 10% FBS (Gibco), 1% MEM non-essential amino
acid solution (Sigma), antibiotic-antimycotic solution
(Gibco); 2 mM L-Glutamine (EMD Millipore) and
3.51g/L D-Glucose (Sigma). Before EV isolation, H9c2
cells were differentiated according to Ménard et al. [14].
Cells were cultured up to confluence, then they were
cultured for a day in DMEM medium supplemented
with 1% FBS (Gibco), and for an additional week in
DMEM medium supplemented with 1% FBS (Gibco)
and 10 nM retinoic acid (Sigma). EVs were isolated
from serum-free conditioned medium.
HL1 immortalised mouse cardiomyocyte cell line
(SCC065) was purchased from Merck and was cultured
according to the instructions of the manufacturer.
Once the cells reached confluence, they were cultured
for an additional day (when spontaneous contractions
of the cells were detectable). EVs were isolated from
serum-free conditioned medium.
THP-1 human leukemic monocyte cell line (from
ECACC through Sigma-Merck) was cultured as
described previously [15]. The cell line was cultured
in RPMI medium containing 10% FBS (Gibco), 2 mM
glutamine (EMD Millipore) and 1% antibiotic-
antimycotic solution (Gibco). EVs were isolated from
serum-free conditioned medium.
EV isolation from conditioned cell culture medium
EVs were purified with minor modifications to what has
been described previously by Osteikoetxea et al. [11]. Prior
to isolation, cells were washed three times with PBS, and
EV production was allowed to take place for 24 h either in
serum-free medium or in the presence of 12.5% EV-
depleted FBS (Gibco). Three different size-based subpopu-
lations were isolated including large EVs (lEV), mid-sized
EVs (mEVs) and small EVs (sEV) by the combination of
gravity driven filtration and differential centrifugation.
Briefly, cells were removed by centrifugation at 300 g for
10 min at room temperature (RT), and then the super-
natant was filtered by gravity through a 5 μm filter
(Millipore, Billerica, MA) and submitted to a 2,000 g cen-
trifugation for 30 min at 4°C to pellet lEVs (Avanti J-XP26
centrifuge, JA 25.15 rotor, Beckman Coulter Inc.). The
supernatant was next filtered by gravity through a 0.8 μm
filter (Millipore), and centrifuged at 12,500g for 40 min at
4°C to pellet mEVs (Avanti J-XP26 centrifuge, JA 25.15
rotor, Beckman Coulter Inc.). Finally, the supernatant was
filtered by gravity through a 0.22 μm filter (Millipore) and
ultracentrifuged in an Optima MAX-XP bench top ultra-
centrifuge with MLA-55 rotor (Beckman Coulter Inc.) at
100,000 g for 70 min at 4°C to pellet sEVs. Each EV pellet
was resuspended once in phosphate-buffer-saline (PBS),
and recentrifuged under the same conditions as used ori-
ginally for pelleting.
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Lipid determination using a commercially available
lipid kit
Determination of EV preparations was carried out by
using a commercially available kit (Quantification Kit,
STA-613 Cell Biolabs, Inc.) following the instructions of
the manufacturer. Lipid standard provided in this kit was
also used for validation of liposome standards.
Optimisation of the SPV lipid assay for EVs
Preparation of liposomes
As a lipid standard, 1,2-Dioleoyl-sn-glycero-3-phos-
phocholine (DOPC) liposomes were used in 1 mg/
mL concentration. DOPC was purchased from
Sigma-Aldrich in lyophilised form. DOPC liposomes
in PBS were prepared as described previously [16].
Briefly, 1 mg DOPC was dissolved in 1 mL chloro-
form (Reanal) in a 2 mL test tube. Chloroform was
evaporated at 60°C in a thermoblock (Labnet) under
a fume hood. Next, PBS was added to the dried
DOPC cake, and the tube was vortexed intensively
for 2 min at maximum speed (Fisherbrand). The
resulting crude liposome suspension was then soni-
cated with 35 kHz (Emmi 20, EMAG) at 45°C for
10 min followed by an additional 2 min intensive
vortexing. The obtained liposome standard was
stable at 4°C for at least 3 months; however, imme-
diately before use, intensive vortexing of the standard
was essential.
As controls, fully saturated liposomes (1,2-Dipalmitoyl-
sn-glycero-3-phosphocholine, DPPC liposomes) and lipo-
somes with 50–50 mol% of DOPC and DPPC were pre-
pared. DPPC was purchased from Sigma-Aldrich in
lyophilised form. Liposome suspensions were prepared as
described for DOPC. In case of liposomes containing both
DOPC and DPPC, lipids were mixed in chloroform before
evaporation of the solvent.
Preparation of phospho-vanillin reagent
An optimised phospho-vanillin reagent was introduced
to increase the sensitivity of the lipid assay described
originally by Fings et al. [17,18] and first used for the
detection of EVs by Osteikoetxea et al. [11]. Briefly,
50 mg vanillin (Sigma) was dissolved in 50 mL of 17%
phosphoric acid (Sigma). Thus, the final vanillin con-
centration was increased five times compared to what
has been used earlier [11]. The phospho-vanillin
reagent was stable at 4°C in dark for at least 3 months.
Determination of lipid content of EVs by the SPV
assay
A volume of 200 µL of 96% sulphuric acid (Molar
Chemicals) was added either to 40 µL of liposome
standards or to 40 µL EVs suspended in PBS or deio-
nised water or NaCl HEPES buffer in 1.5 mL test tubes
(Safe-Lock tubes, 1.5 mL, 0030 120-086, Eppendorf
AG, Germany). The plastic composition and possible
coating or wall component of the test tube were found
to be critical for the success of the assay. We found that
some test tubes, such as 1.5 mL tubes (LoBind T330-
7LST Simport, Canada), may contain surface coats that
can possibly interact with components of the assay and
may cause artefacts.
After a brief vortexing, the open test tubes were
incubated at 90°C (AccuBlock digital dry batch,
Labnet) in a fume hood for 20 min. Tubes were cooled
down to RT by placing them for at least 5 min at 4°C,
and 120 µL of phospho-vanillin reagent was added to
each tube and was vortexed. Next, 280 µL of each
sample was transferred to a 96 well plate (Thermo)
and the colour reaction was allowed to develop for
1 h at 37°C. Absorbance at 540 nm was determined
with a plate reader (Multiskan MS, Labsystems).
Indirect determination of EV lipid concentration
using ATR-FTIR spectroscopy
IR spectra were recorded by the means of a Varian
2000 FTIR spectrometer (Varian Inc., US) equipped
with a Mercury-Cadmium-Telluride detector and
a single reflection diamond ATR accessory (Specac
Ltd, UK). A volume of 3 μL of the sample was placed
on the top of the diamond ATR crystal and dry film
spectra were collected (64 scans, 2 cm−1 spectral
resolution) after solvent evaporation. At least three
parallel measurements were done. A spectroscopic
protein-to-lipid ratio (P/Lspectr) was determined
using the protocol described in [12]. Briefly, after
PBS background spectral subtraction, the relative
amount of protein was estimated by the integrated
intensity of protein Amide I band (around
1650 cm−1) while the lipid content was approximated
by the integrated area of C-H stretching bands from
the 3020–2800 cm−1 wavenumber region. Conversion
of the spectroscopic protein-to-lipid ratio (P/Lspectr)
to nominal protein-to-lipid ratio (P/Lnom) required
an adequate calibration curve. For this purpose,
BSA–Brain Total Lipid Extract mixtures prepared in
PBS buffer with varying protein-to-lipid ratios (from
0.2 to 4 mg/mg) were used.
Determination of size distribution and
concentration of EVs
Size distribution and concentration of H9c2-derived
mEVs and DOPC liposomes were determined by
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tuneable resistive pulse-sensing analysis using a qNano
instrument (IZON Science) as described previously
[19]. In case of mEVs, twofold dilution of the sample
(derived from 24 mL cell supernatant) was prepared in
0.2 μm filtered PBS. For DOPC liposomes, the DOPC
liposome standard (with 1 mg/mL DOPC concentra-
tion) was 10-fold diluted with 0.2 μm filtered PBS and
filtered with a 0.8 μm mesh filter (Millipore). Both
samples were measured by qNano. At least 700 parti-
cles were counted using 10 mbar pressure (mEV) and
3 mbar pressure (DOPC liposomes) using a NP400
nanopore membrane. Calibration was performed with
known concentration of beads CPC400G (mean dia-
meter: 340 nm, purchased from IZON), diluted 1:1000
in 0.2 μm filtered PBS. Results were evaluated using
IZON Control Suite 3.2 software.
Determination of protein content of EVs using BCA
Protein concentration of EVs was determined with the
Micro BCA Protein Assay kit (Thermo) according to the
instructions of the manufacturer. Briefly, EVs were diluted
5–10 times and were lysed with 0.5% Triton X-100 (Sigma)
and 0.05% SDS (Sigma). Colour was developed for 1 h at
60°C and absorbance at 562 nmwasmeasured (NanoDrop
NP-1000 ThermoFisher).
Detection of EVs and liposomes by transmission
electron microscopy (TEM)
Detection of EVs and liposomes with
phosphotungstic acid contrasting
A volume of 2 µL of sample suspended in 0.22 µm filtered
PBS was placed onto the surface of 300 mesh formvar-
coated grids, and was incubated for 10 min at RT. The
residual liquid was removed, and the samples were fixed
(10 min at RT) with 4% glutaraldehyde diluted in 0.22 µm
filtered PBS. After fixation, grids were washed 3 times
(5 min) at RT with purified water and were contrasted
with 2% phosphotungstic acid (10 min, RT) followed by
3 × 1 min washes. Samples were examined by JEOL 1011
transmission electron microscope (Japan).
Detection of EVs by immunoelectron microscopy
For immunoelectron microscopy, 2 µL of sample resus-
pended in 0.22 µm filtered PBS was placed onto the sur-
face of 300 mesh formvar-coated Ni grids, and was
incubated for 10 min at RT. Then the residual liquid
was removed, and the samples were fixed (10 min at
RT) with 0.22 µm filtered 4% paraformaldehyde in PBS,
and washed 3 times for 5 min, at RT with 0.22 µm filtered
PBS. For blocking, 1 h incubation with 0.22 µm filtered
5% BSA (Sigma) in PBS was used. As primary antibodies,
polyclonal rabbit anti-CD63 IgG (H-193, sc-15363, Santa
Cruz Biotechnology), monoclonal mouse anti-CD81
(1.3.3.22, ThermoFisher Scientific) or polyclonal rabbit
anti-CD81 (FNab01501, FineTest) were applied over-
night at 4°C in 1:50 dilution in 0.22 µm filtered 5% BSA
in PBS. After washes (3 times 5 min with 0.22 µm filtered
5% BSA), polyclonal goat anti-rabbit IgG 10 nm gold pre-
adsorbed (Abcam) or polyclonal goat anti-mouse IgG
5 nm gold pre-adsorbed (Sigma) were used for 3 h at
RT. Samples were than washed 3 times for 5 min with
0.22 µm filtered 5% BSA, 3 times for 5 min with 0.22 µm
filtered PBS and 3 times for 5 min with purified water.
Finally, permanent fixation by 2% glutaraldehyde was
applied for 10 min at RT followed by 3 times 5 min
washes with purified water. For background contrasting,
2% phosphotungstic acid was used (10 min RT) followed
by 3 × 1 min washes. Samples were examined by JEOL
1011 transmission electron microscope (Japan).
Determination of EV-related surface adhesion
signal
EV-related surface adhesion signal of THP-1 cell-
derived sEVs was determined as previously described
by Németh et al. [19]. For the measurements, an EPIC
BenchTop system (Corning Inc.) was used with
Corning EPIC 384 Well Cell Assay Microplates.
Changes in the refractive index caused by adhesion of
EVs onto the surface were recorded. Bare surface signal
correlated with the quantity of EVs.
Results
Modification of the lipid assay by introducing
a liposome standard and using an elevated vanillin
concentration
As a first step in our attempt to optimise the previously
described lipid assay [11,17,18,20,21], we introduced an
aqueous phase liposome standard prepared from DOPC
enabling an organic solvent-free lipid detection. One of
the shortcomings of the previously used lipid assays is
that lipid standards are dissolved in organic solvents.
Organic solvents do not only impose health hazards, but
their intense evaporation (i) often causes inaccuracy of
pipetting and (ii) results in an increased concentration
over time due to loss of solvent. Importantly, when lipid
samples contain organic solvents (such as chloroform,
dimethyl sulfoxide (DMSO) or acetone), a yellowish col-
our develops (Figure 1(a)). Even though this colour
shows correlation with the lipid content of the samples,
the specificity and sensitivity of this reaction does not
enable lipid determination. If the reaction mixture
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contains less than 8 µg lipid (which is the case for most
EV preparations) the absorbance is only approximately
0.04) (Figure 1(b)). The same phenomenon is mentioned
in the technical notes of the commercial lipid quantifica-
tion kit used in this study which is also based on the SPV
assay. The manufacturer of the kit recommends subtrac-
tion of this yellowish background colour from the read at
540 nm after SPV reaction. In our modified lipid assay,
we omitted organic solvents from the quantification
method, and both our standards and samples were in
aqueous phase. Thus, without organic solvents, we did
not observe the yellow background colour (Figure 1(a,b)).
Next, we set the standard curve from 0.25 to 16 µg
DOPC in 40 µL (6.25–400 ng/mL) using our new
liposome standard and the modified lipid assay with
an increased vanillin concentration. As shown in
Figure 2, the correlation (Pearson’s r value) between
the absorbance at 540 nm and the lipid concentration
is close to 1.00; therefore, the modified assay is suitable
for detection of lipids in aqueous phase.
Validation of the modified lipid assay
The next key question we addressed was if the mod-
ified lipid assay was suitable of measuring the lipid
content of EV samples. The vanillin-based detection
only measures unsaturated lipids [21]. In
Supplementary Material (S1) using DOPC (unsatu-
rated) and DPPC (fully saturated) standards, we show
evidence for the differential sensitivity of the assay for
saturated and unsaturated lipids.
Based on the paper of Llorente et al [22], we also
performed an estimation of how the variable levels of
unsaturated lipids in EVs may affect results of the SPV
assay (S2). The result of our estimation was that while
the plasma membrane of PC-3 prostate cancer cells
contained approx. 2.14 mmol unsaturated carbon
bonds/g lipids, sEVs contained approx. 2.10 mmol
unsaturated carbon bonds/g lipids (a surprisingly
close value). For comparison, DOPC has 2.54 mmol
unsaturated carbon bonds/g lipids. Therefore irrespec-
tively whether the saturation level differs between EVs
and the plasma membrane, the mmol value of unsatu-
rated carbon bonds/g lipids remains constant. Thus,
the detected MS differences may not affect the results
of the SPV assay significantly.
Next, we isolated EVs from the conditioned media
of two T175 confluent tissue culture flasks (24 h serum
free) of AC16, HL1 and H9c2 cells. The volume of the
conditioned medium was 2 × 12 mL. As shown in
Table 1, 15% of our EV preparation was enough to
give readily detectable lipid results with the optimised
Figure 1. Organic solvents cause artificial colouration. (a) Yellow colour develops when the reaction mixture contains organic
solvent (e.g. DMSO). The figure shows wells containing decreasing amounts of DOPC (from the top: 16, 8, 4, 2, 1, 0.5, 0.25 and 0 µg)
before addition of the phospho-vanillin reagent (after 90°C 20 min incubation). Reaction mixtures in the wells of the left column do
not contain DMSO while in the right column they contain 20 µL DMSO/well. (b) Absorbance at 540 nm (arb: arbitrary units).
Background of the reaction before adding phospho-vanillin reagent without DMSO is indicated as “w/o DMSO” while background
with 20 µL DMSO is labelled as “w DMSO”. Scale of Y-axis was set to the axis of a standard SPV assay. Insert panel shows the curves
with a zoomed Y-axis to make the linearity visible. The figure shows the result of a single representative measurement.
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lipid assay. Protein concentration of the EV samples
was determined and the presence of EV membrane
markers (CD63 and CD81) was confirmed by immu-
noelectron microscopy (Figure 3). Representative TEM
pictures of EVs contrasted with phosphotungstic acid
are shown in Supplementary file S3.
The lipid assay was validated further with mEVs
obtained from serum-free conditioned media of differ-
entiated cells of H9c2 and AC16 cell lines as well as
with commercial LDL.
The lipid content of mEVs was determined by both
the new liposome-based colorimetric lipid assay and
with the previously described ATR-FTIR spectroscopy-
based method [12]. The amount of lipids was calculated
from spectroscopic and nominal P/L ratio with the help
of the protein concentration determined by Micro BCA
test (calculation can be found in Supplementary file S4).
Results of our optimised lipid assay and ATR-FTIR are
summarised in Table 2. The detected lipid content of
mEVs was found equal using the two independent
methods while the standard deviation of our colori-
metric assay was found 10× lower as compared with
the ATR-FTIR-based method.
As the SPV assay cannot differentiate lipids and
lipoproteins, next the lipid content of an LDL sample
(with 5 mg/mL protein content) was measured. The P/
L percentage was experimentally found 24.89% ± 1.8%
which is in a good agreement with the literature data
where the P/L percentages of LDL were between 23%
and 26% [23].
Size and concentration of mEV particles (H9c2 cell
line) and 10 times diluted, 0.8 µm filtered DOPC lipo-
some standard were determined by qNano (Figure 4).
Total membrane surface/mL was calculated from both
the diameter and the concentration of the particles.
Lipid content of the samples was determined by the
optimised lipid assay. We have found that the EV
preparation contained 5.50 × 10−16 µg lipid/nm2 while
Figure 2. Standard curve of the improved lipid assay. Typical standard curve with three replicates of the optimised sulfo-phospho-
vanillin lipid assay using DOPC liposome standard and optimised vanillin concentration. arb: arbitrary units, error bars refer to SD.
Insert graph in the left panel highlights the standard curves between 0 and 2 µg DOPC. The right panel shows the colorimetric
reaction in a 96 well plate.
Table 1. Lipid contents of EVs isolated from two T175 conflu-
ent tissue culture flasks. EVs were isolated from 24 mL serum-
free conditioned medium (24 h). Sixteen per cent of EVs (5 μL
out of 30 μL was used for lipid measurements).
Cell type EV type Lipid content of EVs
AC16 Large EVs 37.84 µg
AC16 Medium size EVs 21.60 µg
AC16 Small EVs 9.74 µg
HL1 Large EVs 36.34 µg
HL1 Medium size EVs 57.29 µg
HL1 Small EVs 16.63 µg
H9c2 Large EVs 3.07 µg
H9c2 Medium size EVs 4.29 µg
H9c2 Small EVs 2.88 µg
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the liposomes contained 1.22 × 10−15 µg lipid/nm2. The
result shows that DOPC liposomes contain approxi-
mately 2.2 times more lipids compared with EVs. The
difference is caused by membrane proteins of the EV
membrane and/or protein aggregates potentially co-
isolated with the EVs.
To address the question of interference with the
optimised assay by potential components of EV
Figure 3. Detection of EV markers by immunoelectron microscopy using nanogold labelling. (a, b) HL-1 cell line-derived mEVs and
sEVs, respectively. (c) THP-1 sEVs. (d, e) AC16 cell-derived mEVs and sEVs, respectively. (f, g) H9c2cell-derived mEVs and sEVs,
respectively. Gold particles with 10 nm diameter represent CD63 (a, c, d, e, f and g) and CD81 (b). Gold particles with 5 nm diameter
indicate CD81 (c, d, e, f and g). We have found that mEVs were CD81 negative and CD63 positive. In case of HL-1 cell line double
labelling was not possible with the used antibodies, HL-1 mEVs were found CD63 positive while HL-1 sEVs were CD81 positive.
Table 2. Lipid contents of medium-sized EVs measured by the
optimised bench top assay and by the IR-based semi-quantitative
method. EVs were isolated from 24 mL serum-free conditioned
medium (24 h). Mean of three technical replicates ± SD.
Sample
Protein
concentration
(ng/µL)
Lipid
concentration – new
SPVassay (ng/µL)
Lipid
concentration – IR
method (ng/µL)
mEV H9c2 101.7 ± 2.9 114.5 ± 3.1 144.5 ± 68.6
mEV AC16 86.6 ± 2.6 105.1 ± 1.5 113.9 ± 39.4
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preparations, we added increasing concentrations of
proteins and nucleic acids (DNA) to 2.5 µg DOPC
liposomes, and assessed the 540 nm absorbance
values. As summarised in Table 3, neither protein
nor DNA concentration of the sample affected the
lipid detection by the optimised assay.
In addition, here we show an example in which
EVs were isolated from either conditioned or non-
conditioned medium samples supplemented with
12.5% EV-depleted serum (Gibco). The protein and
lipid contents of the EV preparation were compared
(Table 4). As shown in the table, all samples con-
tained significant and relatively similar amounts of
proteins. Importantly, lipid content was only measur-
able from the conditioned media.
Finally, correlation between the amount of EVs and
either their protein or lipid concentration was studied.
We have described previously that the bare surface signal
Figure 4. Particle size and concentration of medium-sized EVs and DOPC liposomes. Medium-sized EVs were isolated from serum-
free conditioned media of H9c2 cells. DOPC liposome standard (1 mg/mL) was ten times diluted in PBS and filtered through 0.8 µm
pore size membrane. Both samples were measured by qNano with NP400 membrane. (a) shows a representative bar chart of H9c2
EVs (H9c2 mEV) and liposomes (DOPC liposome), and (b) shows the DOPC liposomes and C a H9c2 mEV with transmission
electronmicroscope using phosphotungstic acid contrasting.
Table 3. Protein and nucleic acid interference with the lipid assay. The presence of proteins or nucleic acids does not affect the
optimised lipid assay. Bovine serum albumin (BSA) was used as a test protein and genomic DNA extracted from Saccharomyces
cerevisiae cells was used as test nucleic acids. arb: arbitrary unit.
Absorbance (arb) Replicates Student t-test
Protein concentration (µg) Average SD n p = One-way ANOVA
0.0 0,1839 0.0213 6 F (0.2894) < Fcrit (2.6143)
Protein (BSA) concentration significantly do not change the mean
absorbance at 540 nm
0.63 0.1830 0.0076 3 0.9463
1.25 0.1830 0.0176 3 0.9512
2.50 0.1953 0.0068 3 0.4076
5.00 0.1917 0.0184 3 0.6642
10.00 0.1867 0.0101 3 0.8414
20.00 0.1933 0.0105 3 0.5020
40.00 0.1842 0.0262 3 0.9891
Absorbance (arb) Replicates Student t-test
DNA concentration (ng) n p = n p = One-way ANOVA
0.0 0.1355 0.0178 6 F (0.3354) < Fcrit (2.5435)
DNA concentration significantly do not change the mean absorbance at
540 nm
15.6 0.1270 0.0066 3 0.4629
31.3 0.1273 0.0176 3 0.5366
62.5 0.1323 0.0074 3 0.7822
125.0 0.1410 0.0174 3 0.6740
250.0 0.1310 0.0017 3 0.6862
500.0 0.1313 0.0157 3 0.7428
1000.0 0.1300 0.0121 3 0.6500
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of an EPIC optical biosensor correlates with the concen-
tration of EVs [19]. Here, we compared the bare surface
EPIC signal with the protein concentration (measured
with Micro BCA method) and the lipid concentration
(measured with the optimised lipid assay). As Figure 5
shows, the bare surface signal of EPIC had a good corre-
lation with the lipid concentration of the samples while it
did not correlate with the protein concentration.
Comparison of the optimised lipid assay with
a commercial lipid kit
First, we have compared the standard curves of the
commercial lipid kit (following the instructions of the
manufacturer) and our optimised lipid assay. We
determined the relative standard deviation and percen-
tage of RSD values (Figure 6). It is widely accepted that
the precision of an assay is required to be within 20%
RSD [24]. As shown in the figure, the 20% RSD value
was reached at approximately 0.4 µg lipid in 40 µL with
the optimised lipid assay as compared to 1.6 µg in
20 µL lipid in the case of the commercial lipid kit.
This means that the sensitivity of the optimised lipid
assay is approximately one order of magnitude higher
than that of the commercial assay.
Finally, we also compared the newly introduced
DOPC liposome standard. We measured the conven-
tional, purified lipid standard of the commercial kit
along with our DOPC standard by our novel, opti-
mised assay. Since the commercial standard is dis-
solved in DMSO in the kit, we ensured that the 40 µL
sample volume contained 10 µL DMSO and 30 µL PBS
in the case of both (liposome and purified lipid) stan-
dards. The presence of DMSO explains the lower sen-
sitivity of the assay in this case (Figure 7, and statistics
is summarised in Supplementary Table S5).
Importantly, the DOPC and the purified lipid stan-
dards (in the 0.25–16 µg lipid range) did not differ
significantly in our assay.
Discussion
There is an urgent need in the EV field to develop a reliable
and reproducible method for the standardisation of EV
Figure 5. Correlation between the lipid and protein concentrations of EVs with the “bare surface signal” of an EPIC optical
biosensor. Correlation between the EPIC “bare surface signal” and either the lipid concentration (a) or the protein concentration (b).
Small EVs were isolated from serum-free conditioned medium of THP-1 cells. Data points are average of three replicates, error bars
represents SD.
Table 4. Protein and lipid concentrations of small and medium-
sized AC16 EVs. Protein concentrations of mEV and sEV vesicles
were determined by Micro BCA kit (Thermo). The lipid concen-
tration was assessed by the optimised lipid assay. EVs (mEVs
AC16 and sEVs AC16) were isolated form 24 mL conditioned
medium (24 h) of two confluent T175 flasks of AC16 cell
culture. The tissue culture medium contained 12.5% EV-
depleted serum (Gibco). mEV medium and sEV medium are
technical controls of 24 mL non-conditioned medium, contain-
ing 12.5% EV-depleted serum (Gibco).
Protein
concentration
(ng/mL)
Lipid
concentration
(ng/mL)
Protein/lipid ratio
(medium
background
subtracted)
mEV AC16 205.00 21.83 2.52
sEV AC16 206.67 17.16 2.04
mEV Medium 150.00 ND N/A
sEV Medium 171.67 ND N/A
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samples. Currently, the best practice is combining the
quantification of total protein content and the particle
number [6]. However, results obtained this way can be
still confounded by the presence of protein aggregates in
the EV sample resulting in overestimation of EV
concentration.
Figure 6. Percentage RSD of the optimised lipid assay and of a commercial lipid assay. Dashed line indicates 20% RSD which is the
recommended acceptance limit for validations by ICH Quality Guidelines.
Figure 7. Comparison between the DOPC standard and the standard provided by the manufacturer of a commercial lipid kit. Both
the DOPC liposome standard and the purified lipid standard of the commercial kit were measured by our optimised lipid assay.
A volume of 10 µL DMSO was included in the 40 µL sample volume since the purified lipid standard was dissolved in DMSO.
Reduced absorbance values were due to the presence of DMSO in the reaction mixture. Absorbance of DOPC liposome standard and
standard of the commercial kit statistically do not differ at any concentration points. Insert graph highlights the results in the
concentration range between 0 and 50 µg/mL. Data points represent average of three replicates, error bars shows SD. Statistics of
the figure can be found in S5 Supplementary Table.
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Our group has published recently a simple benchtop
lipid assay for EVs [11]. During the period that has passed
since this publication, we recognised that the lipid assay
required more EVs than what researchers could easily
spare from their preparations for determining the lipid
content of the EV sample. Realising this apparent need we
kept optimising the assay, and increased its sensitivity by
approximately 10-fold.We increased the sensitivity of the
previous assay by introducing an aqueous phase DOPC
liposome standard instead of purified lipids dissolved in
organic solvents as described previously [11,17,18,20,21],
and by using an optimised phospho-vanillin reagent con-
centration. The sensitivity of the lipid test is now close to
the one of the frequently used protein Micro BCA assay.
The quantification limit of the assay with 20% RSD is
approximately 0.5 µg lipid with 0.2 µg detection limit
(Table 4) that makes the assay suitable for routine stan-
dardisation of EV samples. If the preparation is pure
enough, an EV sample with approximately 0.5–1 µg pro-
tein content is sufficient for the lipid assay. Combining
the lipid assay with a colorimetric protein measurement
(e.g. Micro BCA), the quality of the EV samples (the
presence of possibly co-isolated protein aggregates) can
be quickly and easily tested as we confirmed earlier [11].
The assay is not influenced by nucleic acids and proteins
(Table 1); however, the sample buffer should not be
significantly contaminated with molecules that can be
heavily oxidised by sulphuric acid (such as sugars). In
addition, residual iodixanol through its benzyl rings can
increase the background of the assay. Of note, molecules
that interfere with the lipid assay (such as sugars) may
also interfere with the protein colorimetric assays [7]. As
highlighted in the section “Material and Methods”, the
quality of plastic ware and the purity of the reagents are
also essential.
The importance of lipid determination is strongly
supported by our observation that only lipid measure-
ment could discriminate between mock and EV-
containing isolates (supplemented with EV-depleted
foetal bovine serum). However, as our lipid assay can-
not distinguish between membrane lipids and lipopro-
teins, standardisation of EV samples from blood
plasma remains challenging [9].
The vanillin-based SPV assay measures unsaturated
lipids. The mol% of unsaturated lipids may vary between
different EV preparations. Furthermore, the profiles of
biological membranes are not constant for a particular
cell type, and the mol% of unsaturated lipids depends on
nutrient and culture conditions [25]. However, if the level
of unsaturation is expressed in mmol unsaturated carbon
bonds/g lipids (which is the key parameter measured by
the SPV assay), the variations seem to be disappear
between different mammalian lipid membrane samples.
This may sound unexpected if we consider that sEV
membrane lipids are more saturated than those of the
plasma membrane (as well as membranes of the plasma
membrane-derived medium/large EVs). Importantly, the
membranes of sEVs contain approximately twice as
much cholesterol as compared to the plasma membrane
[22]. Of note, cholesterol has 2.58 mmol unsaturated
carbon bonds/g lipid, which is higher than the average
carbon bond/g lipid of a plasma membrane. The
increased cholesterol concentration in sEV membranes
may thus compensate for the increased level of saturated
phospholipids in sEVs. Therefore, the difference between
plasma membrane and sEV membranes may disappear
because of the increased cholesterol level (if saturation is
expressed in mmol unsaturated carbon bond/g lipid, the
parameter detected by the SPV assay). In the case of
DOPC liposomes used as standards, the unsaturation
level is close that of the biological membranes.
Results obtained with the EPIC biosensor system show
that the lipid content of a sample provides much more
reliable information on EVs as compared to determination
of total protein concentration (Figure 5). Furthermore, we
obtained the reported P/L ratio in the case of a commercial
LDL sample [22]. Finally, we have obtained comparable
results both with the DOPC liposome standard and the
commercially available lipid standard (Figure 7).
In this study, we also used a simple immunoelectron
microscopy approach which made it possible to identify
EVs based on their protein markers without the need for
cryo-electronmicroscopy. This approach provides infor-
mation about the origin of the detected particles and for
EV research it makes immunoelectron microscopy avail-
able for a wide range of laboratories.
Our assay can be used virtually in any standard
laboratories where a fume hood, a thermo block, and
a spectrophotometer are available (Supplementary video
S6). It does not require expensive equipment (unlike IR
spectroscopy or MS) and is free from aggregates that
lipofil fluorescence dyes may form. In spite of its limita-
tions (measuring unsaturated carbon bonds only and
not being able to differentiate between lipids and lipo-
proteins), the optimised assay can be an easy, reliable
and quick method for quantification of EVs and stan-
dardisation of EV experiments. Even if the SPV assay
may not serve as a single stand-alone technique for EV
standardisation, it may prove very helpful in combina-
tion with either protein or particle measurements and it
may provide a novel basic tool for EV standardisation.
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